Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Postmenopausal Women With Osteoporosis
View Full LandscapeTarget Indication
Postmenopausal Women With Osteoporosis
Clinical Trial
NCT01631214Last updated: 1/10/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Evenity
Evenity is indicated in treatment of severe osteoporosis in postmenopausal women at high risk of fracture.
View on EMA